Found 492 matching trials
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma PHASE2 The study is being conducted to evaluate the efficacy and safety of convers...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01) PHASE3 This trial is a registrational Phase III, randomized, open-label, multicent...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis PHASE3 This is a 5-year project, involving 185 partners from 46 countries ((110 in...
Show More Location
Istituto Giannina Gaslini
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 PHASE2 Background:
Colorectal cancer is a common cancer in the Unites States (U.S...
Show More Location
Lombardi Comprehensive Cancer Center
Learn More & Join Trial
KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer PHASE2 This phase II clinical trial is evaluating whether adding KRC-01 injections...
Show More Learn More & Join Trial
Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients PHASE2 Mucositis is a common and clinically significant side effect of both antica...
Show More Learn More & Join Trial
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma N/A Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction PHASE2 Our main objective is to evaluate the effect of Ocoxin-Viusid on the qualit...
Show More Location
National Institute of Oncology and Radiobiology (INOR)
Learn More & Join Trial